Regeneron Pharmaceuticals, Inc. (REGN) - NASDAQ
  • Alexander Valtsev | Send Message 20 Jul

    Why I Bought Shares of Regeneron Pharmaceuticals Inc. Last Week: $IBB $REGN $SNY
      • Alexander Valtsev | Send Message 19 Jul

        Three Biotech Stocks to Buy and Hold: $GILD $CELG $REGN $IBB
          • Alexander Valtsev | Send Message 12 Jul

            Instant Analysis: Amgen's Latest Approval Raises the Bar on Regeneron Pharmaceuticals and Sanofi: $SNY $AMGN $REGN
              • Alexander J. Poulos | Send Message 11 Jul

                A Review Of The Components Of The iShares Biotech ETF: Regeneron Pharmaceuticals $REGN
                  • Scott Wachsler | Send Message 9 Jul

                    The Wax Report - Week Ending 07/08/2016 $REGN, $TRN, $MXWL
                      • Matt Hogan | Send Message 8 Jul

                        Watch For Regeneron's EBITDA Margin On Earnings Day $REGN
                          • Alexander Valtsev | Send Message 1 Jul

                            Here's Why Regeneron Pharmaceuticals Inc Is Down 35% This Year: $REGN
                              • Paul Johnson | Send Message 29 Jun

                                Analyst upgrades: $BIIB, $JAZZ, $HZNP, $REGN started w/ outperform; $CASY, $IPGP upped to buy; $FLTX started w/ overweight.
                                  • Nicholas Ward | Send Message 27 Jun

                                    Just initiated a small position in $REGN in my roth @ 331.10. Beaten down company with great growth prospects. Long-term holdings here.
                                      • Avner Amram | Send Message 22 Jun

                                        Regeneron(REGN) Timing And Support On Weekly Chart $REGN
                                          Company Description
                                          Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer and a rare inflammatory condition... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States